摘要:
Background:
A family of 4H-benzo[d][1,3]oxazines were obtained from a
group of N-(2-alkynyl)aryl benzamides precursors via gold(I) catalysed chemoselective
6-exo-dig C-O cyclization.
Method:
The precursors and oxazines obtained were studied in breast cancer cell lines
MCF-7, CAMA-1, HCC1954 and SKBR-3 with differential biological activity showing
various degrees of inhibition with a notable effect for those that had an aryl substituted
at C-2 of the molecules. 4H-benzo[d][1,3]oxazines showed an IC50 rating from 0.30 to
157.4 µM in MCF-7, 0.16 to 139 in CAMA-1, 0.09 to 93.08 in SKBR-3, and 0.51 to
157.2 in HCC1954 cells.
Results:
We observed that etoposide is similar to benzoxazines while taxol effect is
more potent. Four cell lines responded to benzoxazines while SKBR-3 cell line responded to precursors and benzoxazines. Compounds 16, 24, 25 and 26 have the potent effect
in cell proliferation inhibition in the 4 cell lines tested and correlated with oxidant activity suggesting a possible mechanism by ROS generation.
Conclusion:
These compounds represent possible drug candidates for the treatment of
breast cancer. However, further trials are needed to elucidate its full effect on cellular
and molecular features of cancer.